Users of hydrophilic, but not hydrophobic, statins, had a lower risk of being diagnosed with prostate cancer, a large retrospective study found.
Canagliflozin decreases the risk of kidney failure in patients with chronic kidney disease and type 2 diabetes, according to a new study.
Patients with gout who did not reach a serum uric acid level below 6 mg/dL had a 2.4-fold increased risk for death.
Lidocaine patches are being widely used to treat certain types of pain for which they were not approved despite a lack of efficacy evidence, said James D. Ray, PharmD in a session at PAINWeek 2013 titled, “Topical and Transdermal Analgesics.”
Hypnosis can be an effective tool for relieving pain, even the extreme pain associated with burn wound debridement, says David R. Patterson, PhD, Professor in the Department of Rehabilitation Medicine at the University Washington, Seattle at PAINWeek 2013.
Obesity is associated with worse outcomes in pain patients, but losing even modest weight loss can make a substantial difference, said Robert A. Bonakdar, MD, to PAINWeek 2013 attendees.
Restless legs syndrome (RLS) is a common condition that is easy to identify and treat, says Victor Rosenfeld, MD, to attendees of PAINWeek 2013.
Urine drug testing (UDT) can be an important tool in risk evaluation and mitigation strategies (REMS) when used in a patient-centered fashion and it is done “for the patient” rather than “to the patient,” said Howard A. Heit, MD to attendees at PAINWeek 2013.
If acute pain caused by a damaged peripheral nerve is not cured within six weeks the pain will centralize and a patient will be stuck with it for life, Forest Tennant, MD, DrPH told attendees at PAINWeek 2013.
Medicinal cannabis is legal in 20 states, but its illegality under federal law stops many physicians in those states from prescribing it, said Michael E. Schatman, PhD, Executive Director of the Foundation for Ethics in Pain Care at PAINWeek 2013.
